Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

TIGAR inclusion pathology is specific for Lewy body diseases.

Robles López KL, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR.

Brain Res. 2018 Sep 26. pii: S0006-8993(18)30497-9. doi: 10.1016/j.brainres.2018.09.032. [Epub ahead of print]

PMID:
30267647
2.

Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with Either Sporadic or Familial Alzheimer's Disease.

Bell SM, Barnes K, Clemmens H, Al-Rafiah AR, Al-Ofi EA, Leech V, Bandmann O, Shaw PJ, Blackburn DJ, Ferraiuolo L, Mortiboys H.

J Mol Biol. 2018 Oct 19;430(21):3942-3953. doi: 10.1016/j.jmb.2018.08.019. Epub 2018 Aug 29.

3.

The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease.

Schöndorf DC, Ivanyuk D, Baden P, Sanchez-Martinez A, De Cicco S, Yu C, Giunta I, Schwarz LK, Di Napoli G, Panagiotakopoulou V, Nestel S, Keatinge M, Pruszak J, Bandmann O, Heimrich B, Gasser T, Whitworth AJ, Deleidi M.

Cell Rep. 2018 Jun 5;23(10):2976-2988. doi: 10.1016/j.celrep.2018.05.009.

4.

Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care.

Williams U, Bandmann O, Walker R.

J Mov Disord. 2018 May;11(2):53-64. doi: 10.14802/jmd.17028. Epub 2018 May 30. Review.

5.

Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting.

Taylor JC, Romanowski C, Lorenz E, Lo C, Bandmann O, Fenner J.

EJNMMI Res. 2018 May 8;8(1):36. doi: 10.1186/s13550-018-0393-5.

6.

Porphyria: often discussed but too often missed.

O'Malley R, Rao G, Stein P, Bandmann O.

Pract Neurol. 2018 Oct;18(5):352-358. doi: 10.1136/practneurol-2017-001878. Epub 2018 Mar 14. Review.

PMID:
29540448
7.

Animal models of Wilson disease.

Reed E, Lutsenko S, Bandmann O.

J Neurochem. 2018 Aug;146(4):356-373. doi: 10.1111/jnc.14323. Epub 2018 Jun 26. Review.

PMID:
29473169
8.

The subresolution DaTSCAN phantom: a cost-effective, flexible alternative to traditional phantom technology.

Taylor JC, Vennart N, Negus I, Holmes R, Bandmann O, Lo C, Fenner J.

Nucl Med Commun. 2018 Mar;39(3):268-275. doi: 10.1097/MNM.0000000000000801.

9.

Translational approaches to restoring mitochondrial function in Parkinson's disease.

Mortiboys H, Macdonald R, Payne T, Sassani M, Jenkins T, Bandmann O.

FEBS Lett. 2018 Mar;592(5):776-792. doi: 10.1002/1873-3468.12920. Epub 2017 Dec 17. Review.

PMID:
29178330
10.

Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review.

Pezzoli S, Cagnin A, Bandmann O, Venneri A.

Brain Sci. 2017 Jul 15;7(7). pii: E84. doi: 10.3390/brainsci7070084. Review.

11.

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.

Barber TR, Lawton M, Rolinski M, Evetts S, Baig F, Ruffmann C, Gornall A, Klein JC, Lo C, Dennis G, Bandmann O, Quinnell T, Zaiwalla Z, Ben-Shlomo Y, Hu MTM.

Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx071.

12.

Epidemiology and introduction to the clinical presentation of Wilson disease.

Lo C, Bandmann O.

Handb Clin Neurol. 2017;142:7-17. doi: 10.1016/B978-0-444-63625-6.00002-1. Review.

PMID:
28433111
13.

Inhibition of the mitochondrial calcium uniporter rescues dopaminergic neurons in pink1-/- zebrafish.

Soman S, Keatinge M, Moein M, Da Costa M, Mortiboys H, Skupin A, Sugunan S, Bazala M, Kuznicki J, Bandmann O.

Eur J Neurosci. 2017 Feb;45(4):528-535. doi: 10.1111/ejn.13473. Epub 2016 Dec 28.

14.

Genetics of multiple system atrophy: Back to square one?

Bandmann O, Chio A.

Neurology. 2016 Oct 11;87(15):1530-1531. Epub 2016 Sep 14. No abstract available.

PMID:
27629090
15.

Rescue of mitochondrial function in parkin-mutant fibroblasts using drug loaded PMPC-PDPA polymersomes and tubular polymersomes.

Yealland G, Battaglia G, Bandmann O, Mortiboys H.

Neurosci Lett. 2016 Sep 6;630:23-29. doi: 10.1016/j.neulet.2016.06.065. Epub 2016 Jul 10.

16.

Huntington disease: More common than you think?

Delatycki MB, Bandmann O.

Neurology. 2016 Jul 19;87(3):247-8. doi: 10.1212/WNL.0000000000002874. Epub 2016 Jun 22. No abstract available.

PMID:
27335111
17.

Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death.

Keatinge M, Bui H, Menke A, Chen YC, Sokol AM, Bai Q, Ellett F, Da Costa M, Burke D, Gegg M, Trollope L, Payne T, McTighe A, Mortiboys H, de Jager S, Nuthall H, Kuo MS, Fleming A, Schapira AH, Renshaw SA, Highley JR, Chacinska A, Panula P, Burton EA, O'Neill MJ, Bandmann O.

Hum Mol Genet. 2015 Dec 1;24(23):6640-52. doi: 10.1093/hmg/ddv369. Epub 2015 Sep 16.

18.

UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo.

Mortiboys H, Furmston R, Bronstad G, Aasly J, Elliott C, Bandmann O.

Neurology. 2015 Sep 8;85(10):846-52. doi: 10.1212/WNL.0000000000001905. Epub 2015 Aug 7.

19.

Wilson's disease and other neurological copper disorders.

Bandmann O, Weiss KH, Kaler SG.

Lancet Neurol. 2015 Jan;14(1):103-13. doi: 10.1016/S1474-4422(14)70190-5. Review.

20.

pH-sensitive tubular polymersomes: formation and applications in cellular delivery.

Robertson JD, Yealland G, Avila-Olias M, Chierico L, Bandmann O, Renshaw SA, Battaglia G.

ACS Nano. 2014 May 27;8(5):4650-61. doi: 10.1021/nn5004088. Epub 2014 Apr 29.

PMID:
24724711
21.

The documentation of consent and disclosure of neurogenetic testing outside clinical genetics.

Lo C, Martindale J, Hadjivassiliou M, Martin P, Dalton A, Bandmann O.

Neurogenetics. 2014 Mar;15(1):19-21. doi: 10.1007/s10048-014-0391-3. Epub 2014 Feb 11.

PMID:
24515844
22.

Neuronal dark matter: the emerging role of microRNAs in neurodegeneration.

Goodall EF, Heath PR, Bandmann O, Kirby J, Shaw PJ.

Front Cell Neurosci. 2013 Oct 10;7:178. doi: 10.3389/fncel.2013.00178. Review.

23.

TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency.

Flinn LJ, Keatinge M, Bretaud S, Mortiboys H, Matsui H, De Felice E, Woodroof HI, Brown L, McTighe A, Soellner R, Allen CE, Heath PR, Milo M, Muqit MM, Reichert AS, Köster RW, Ingham PW, Bandmann O.

Ann Neurol. 2013 Dec;74(6):837-47. doi: 10.1002/ana.23999.

24.

Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease.

Mortiboys H, Aasly J, Bandmann O.

Brain. 2013 Oct;136(Pt 10):3038-50. doi: 10.1093/brain/awt224. Epub 2013 Sep 2.

PMID:
24000005
25.

C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study.

Cooper-Knock J, Frolov A, Highley JR, Charlesworth G, Kirby J, Milano A, Hartley J, Ince PG, McDermott CJ, Lashley T, Revesz T, Shaw PJ, Wood NW, Bandmann O.

Neurology. 2013 Aug 27;81(9):808-11. doi: 10.1212/WNL.0b013e3182a2cc38. Epub 2013 Jul 24.

26.

The common PARK8 mutation LRRK2G²⁰¹⁹S is not a risk factor for breast cancer in the absence of Parkinson's disease.

Mortiboys H, Cox A, Brock IW, Bandmann O.

J Neurol. 2013 Aug;260(8):2177-8. doi: 10.1007/s00415-013-7027-7. Epub 2013 Jul 4. No abstract available.

PMID:
23824357
27.

Transglutaminase 6 antibodies in the diagnosis of gluten ataxia.

Hadjivassiliou M, Aeschlimann P, Sanders DS, Mäki M, Kaukinen K, Grünewald RA, Bandmann O, Woodroofe N, Haddock G, Aeschlimann DP.

Neurology. 2013 May 7;80(19):1740-5. doi: 10.1212/WNL.0b013e3182919070. Epub 2013 Apr 10.

PMID:
23576621
28.

A genetic study of Wilson's disease in the United Kingdom.

Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, Klaffke S, Joyce CJ, Dhawan A, Hadzic N, Mieli-Vergani G, Kirk R, Elizabeth Allen K, Nicholl D, Wong S, Griffiths W, Smithson S, Giffin N, Taha A, Connolly S, Gillett GT, Tanner S, Bonham J, Sharrack B, Palotie A, Rattray M, Dalton A, Bandmann O.

Brain. 2013 May;136(Pt 5):1476-87. doi: 10.1093/brain/awt035. Epub 2013 Mar 21.

29.

Delayed toxic-hypoxic encephalopathy.

Blackburn DJ, Alix JJ, Sarrigiannis P, Hoggard N, Bandmann O.

Pract Neurol. 2013 Apr;13(2):114-9. doi: 10.1136/practneurol-2012-000402. No abstract available.

PMID:
23468562
30.

Biomarkers for PD: How can we approach complexity?

Berg D, Bandmann O.

Neurology. 2013 Feb 12;80(7):608-9. doi: 10.1212/WNL.0b013e3182825184. Epub 2013 Jan 16. No abstract available.

PMID:
23325899
31.

Heterozygous mutations in the FGF8, SHH and nodal/transforming growth factor beta pathways do not confer increased dopaminergic neuron vulnerability--a zebrafish study.

Lo C, Flinn LJ, Bandmann O.

Neurosci Lett. 2013 Jan 4;532:55-8. doi: 10.1016/j.neulet.2012.10.035. Epub 2012 Nov 2.

PMID:
23123778
32.

The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis.

Quarrell O, O'Donovan KL, Bandmann O, Strong M.

PLoS Curr. 2012 Jul 20;4:e4f8606b742ef3. doi: 10.1371/4f8606b742ef3.

33.

Prolonged generalized dystonia after chronic cerebellar application of kainic acid.

Alvarez-Fischer D, Grundmann M, Lu L, Samans B, Fritsch B, Möller JC, Schaefer MK, Hartmann A, Oertel WH, Bandmann O.

Brain Res. 2012 Jun 29;1464:82-8. doi: 10.1016/j.brainres.2012.05.007. Epub 2012 May 15.

PMID:
22595488
34.

Parkinson disease, cancer, and LRRK2: causation or association?

Bandmann O, Cookson MR.

Neurology. 2012 Mar 13;78(11):772-3. doi: 10.1212/WNL.0b013e318249f744. Epub 2012 Feb 8. No abstract available.

PMID:
22323745
35.

The influence of the zebrafish genetic background on Parkinson's disease-related aspects.

Bretaud S, MacRaild S, Ingham PW, Bandmann O.

Zebrafish. 2011 Sep;8(3):103-8. doi: 10.1089/zeb.2011.0697. Epub 2011 Jul 11.

PMID:
21745139
36.

Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2.

Mortiboys H, Johansen KK, Aasly JO, Bandmann O.

Neurology. 2010 Nov 30;75(22):2017-20. doi: 10.1212/WNL.0b013e3181ff9685.

PMID:
21115957
37.

Genetic zebrafish models of neurodegenerative diseases.

Bandmann O, Burton EA.

Neurobiol Dis. 2010 Oct;40(1):58-65. doi: 10.1016/j.nbd.2010.05.017. Epub 2010 May 20. Review.

PMID:
20493258
38.

Parkinson's disease: insights from pathways.

Cookson MR, Bandmann O.

Hum Mol Genet. 2010 Apr 15;19(R1):R21-7. doi: 10.1093/hmg/ddq167. Epub 2010 Apr 26. Review.

39.

Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: initial findings in adults with neurofibromatosis type 1.

Wignall EL, Griffiths PD, Papadakis NG, Wilkinson ID, Wallis LI, Bandmann O, Cowell PE, Hoggard N.

AJNR Am J Neuroradiol. 2010 May;31(5):856-61. doi: 10.3174/ajnr.A2005. Epub 2010 Mar 18.

40.

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss.

Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ.

Nat Neurosci. 2009 Sep;12(9):1129-35. doi: 10.1038/nn.2372. Epub 2009 Aug 16.

41.

Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio).

Flinn L, Mortiboys H, Volkmann K, Köster RW, Ingham PW, Bandmann O.

Brain. 2009 Jun;132(Pt 6):1613-23. doi: 10.1093/brain/awp108. Epub 2009 May 12.

PMID:
19439422
42.

Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts.

Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S, Wood NW, Willems PH, Smeitink JA, Cookson MR, Bandmann O.

Ann Neurol. 2008 Nov;64(5):555-65. doi: 10.1002/ana.21492.

43.

Yet another spinocerebellar ataxia: the saga continues.

Bandmann O, Singleton AB.

Neurology. 2008 Aug 19;71(8):542-3. doi: 10.1212/01.wnl.0000323932.90720.55. No abstract available.

PMID:
18711106
44.

Immunophenotyping in Tourette syndrome--a pilot study.

Möller JC, Tackenberg B, Heinzel-Gutenbrunner M, Burmester R, Oertel WH, Bandmann O, Müller-Vahl KR.

Eur J Neurol. 2008 Jul;15(7):749-53. doi: 10.1111/j.1468-1331.2008.02159.x. Epub 2008 May 15.

PMID:
18484991
45.

Zebrafish as a new animal model for movement disorders.

Flinn L, Bretaud S, Lo C, Ingham PW, Bandmann O.

J Neurochem. 2008 Sep;106(5):1991-7. doi: 10.1111/j.1471-4159.2008.05463.x. Epub 2008 May 4. Review.

46.

Complicated autosomal recessive hereditary spastic paraplegia: a complex picture is emerging.

Hedera P, Bandmann O.

Neurology. 2008 Apr 15;70(16 Pt 2):1375-6. doi: 10.1212/01.wnl.0000310433.12618.e4. No abstract available.

PMID:
18413565
47.

Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.

Leinweber B, Möller JC, Scherag A, Reuner U, Günther P, Lang CJ, Schmidt HH, Schrader C, Bandmann O, Czlonkowska A, Oertel WH, Hefter H.

Mov Disord. 2008 Jan;23(1):54-62.

PMID:
17960799
48.

Unified Wilson's Disease Rating Scale - a proposal for the neurological scoring of Wilson's disease patients.

Członkowska A, Tarnacka B, Möller JC, Leinweber B, Bandmann O, Woimant F, Oertel WH.

Neurol Neurochir Pol. 2007 Jan-Feb;41(1):1-12.

PMID:
17330175
49.

CNS involvement in hereditary neuropathy with pressure palsies (HNPP).

Tackenberg B, Möller JC, Rindock H, Bien S, Sommer N, Oertel WH, Rosenow F, Schepelmann K, Hamer HM, Bandmann O.

Neurology. 2006 Dec 26;67(12):2250-2.

PMID:
17190957
50.

p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease.

Bretaud S, Allen C, Ingham PW, Bandmann O.

J Neurochem. 2007 Mar;100(6):1626-35. Epub 2006 Dec 12.

Supplemental Content

Loading ...
Support Center